A Brief Intervention to Reduce Suicide Risk in Military Service Members and Veterans- Study 1

NCT01334541 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2019-01-31

No results posted yet for this study

Summary

The investigators propose to evaluate Suicide Assessment and Follow-up Engagement: Veteran Emergency Treatment (SAFE VET) which is currently being implemented in 4 VA ED/Urgent Care Units across the United States (Portland VA Medical Center (VAMC), Denver VAMC, Manhattan VAMC, and Philadelphia VAMC).

Conditions

  • Suicide Risk | Patient

Interventions

BEHAVIORAL

SAFE VET

All SAFE VET EDs provide a standardized intervention that is specifically adapted for use in the ED to mitigate suicide risk. Given that the SAFE VET intervention was developed for use in a busy ED setting, the length of the intervention is approximately 45 minutes. The SAFE VET intervention is administered by a clinical provider who has been specifically trained and consists of: 1. Risk Assessment 2. Safety Planning Intervention: Developed by Stanley and Brown (2008), Safety Planning Intervention consists of a hierarchically-arranged list of coping strategies identified for use during a subsequent suicidal crisis. 3. Clinical Follow-Up Protocol

Sponsors & Collaborators

Principal Investigators

  • Marjan Holloway, Ph.D. · Uniformed Services University of the Health Sciences

  • Gregory Brown, Ph.D. · University of Pennsylvania

  • Lisa Brenner, Ph.D. · Denver VAMC, VISN 19 MIRECC

  • Barbara Stanley, Ph.D. · Columbia University

  • Kerry Knox, Ph.D. · Canadaigua VAMC- Center of Excellence

  • Glenn Currier, M.D. · Canandaigua VAMC- Center of Excellence

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-09-30
Primary Completion
2018-11-30
Completion
2018-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01334541 on ClinicalTrials.gov